Literature DB >> 16140174

Cyclic estradiol replacement attenuates stress-induced c-Fos expression in the PVN of ovariectomized rats.

Marjolein Gerrits1, Asselien Grootkarijn, Berthien F Bekkering, Marieke Bruinsma, Johan A Den Boer, Gert J Ter Horst.   

Abstract

Estradiol modulates stress reactions in female rats. Several studies showed anxiolytic effects of estradiol in behavioral tests, but the underlying mechanisms are still unclear. The aim of the current study was to explore how estradiol-treated rats respond to acute and chronic stress compared to ovariectomized rats. Ovariectomized rats received vehicle or 17beta-estradiol injections (10 microg/250 g) once every 4 days, which induced alternating high and low plasma 17beta-estradiol levels. Stress was presented by daily exposure to an adverse environment in which the animals received five footshocks for either 3 or 22 days. Under control conditions no differences were observed, but as soon as stress was applied, reactions of ovariectomized and estradiol-treated rats diverged. Both acute and chronic stress increased the c-Fos protein expression in the paraventricular nucleus (PVN) of the hypothalamus. Cyclic estradiol treatment reduced this stress-induced activation of the PVN, an effect that seems to be dependent on the plasma estradiol levels. No differences in stress-induced corticosterone responses were revealed between the treatment groups. An increase in the number of ERbeta-expressing cells in the PVN of ovariectomized and estradiol-treated rats during chronic stress implied increased ERbeta-mediated mechanisms during these conditions. The dampening effect of estradiol on the excessive stress-induced activity in the PVN may be beneficial for the animal in its response to chronic recurrent stress by reducing the output of the PVN.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140174     DOI: 10.1016/j.brainresbull.2005.06.021

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  7 in total

Review 1.  Sex differences in psychopathology: of gonads, adrenals and mental illness.

Authors:  Matia B Solomon; James P Herman
Journal:  Physiol Behav       Date:  2009-03-09

2.  17β-estradiol differentially regulates stress circuitry activity in healthy and depressed women.

Authors:  Emily G Jacobs; Laura M Holsen; Katie Lancaster; Nikos Makris; Sue Whitfield-Gabrieli; Anne Remington; Blair Weiss; Stephen Buka; Anne Klibanski; Jill M Goldstein
Journal:  Neuropsychopharmacology       Date:  2014-08-12       Impact factor: 7.853

3.  The organizational role of testicular hormones and the androgen receptor in anxiety-related behaviors and sensorimotor gating in rats.

Authors:  Damian G Zuloaga; Cynthia L Jordan; S Marc Breedlove
Journal:  Endocrinology       Date:  2011-02-15       Impact factor: 4.736

4.  The gad2 promoter is a transcriptional target of estrogen receptor (ER)alpha and ER beta: a unifying hypothesis to explain diverse effects of estradiol.

Authors:  Edward D Hudgens; Lan Ji; Clifford D Carpenter; Sandra L Petersen
Journal:  J Neurosci       Date:  2009-07-08       Impact factor: 6.167

Review 5.  Sex differences in the hypothalamic-pituitary-adrenal axis' response to stress: an important role for gonadal hormones.

Authors:  Ashley L Heck; Robert J Handa
Journal:  Neuropsychopharmacology       Date:  2018-08-01       Impact factor: 7.853

6.  Naturally Occurring Changes in Estradiol Concentrations in the Menopause Transition Predict Morning Cortisol and Negative Mood in Perimenopausal Depression.

Authors:  Jennifer L Gordon; Tory A Eisenlohr-Moul; David R Rubinow; Leah Schrubbe; Susan S Girdler
Journal:  Clin Psychol Sci       Date:  2016-09

7.  Anxiolytic effects and neuroanatomical targets of estrogen receptor-β (ERβ) activation by a selective ERβ agonist in female mice.

Authors:  Mario G Oyola; Wendy Portillo; Andrea Reyna; Chad D Foradori; Andrea Kudwa; Laura Hinds; Robert J Handa; Shaila K Mani
Journal:  Endocrinology       Date:  2011-12-20       Impact factor: 4.736

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.